Podcast
Questions and Answers
What is the primary cause of Coumadin necrosis?
What is the primary cause of Coumadin necrosis?
- Depletion of protein C causing thrombosis (correct)
- Concurrent use of heparin
- Increased levels of procoagulant factors
- Direct skin exposure to Coumadin
Which demographic is at the greatest risk for developing Coumadin necrosis?
Which demographic is at the greatest risk for developing Coumadin necrosis?
- Obese men
- Children under 10
- Elderly patients
- Overweight women (correct)
What condition leads to a transient hypercoagulable state when initiating Coumadin therapy?
What condition leads to a transient hypercoagulable state when initiating Coumadin therapy?
- Excessive vitamin K intake
- Depletion of protein S
- Depletion of protein C (correct)
- Increased platelet count
What prevents Coumadin necrosis during the initiation of Coumadin therapy?
What prevents Coumadin necrosis during the initiation of Coumadin therapy?
Which anatomical areas are most affected by Coumadin necrosis?
Which anatomical areas are most affected by Coumadin necrosis?
What is a characteristic time frame for the onset of DRESS after starting the medication?
What is a characteristic time frame for the onset of DRESS after starting the medication?
Which of the following symptoms is commonly associated with DRESS?
Which of the following symptoms is commonly associated with DRESS?
Which organ system is least likely to be affected by DRESS?
Which organ system is least likely to be affected by DRESS?
What laboratory finding is almost always present in cases of DRESS?
What laboratory finding is almost always present in cases of DRESS?
What is one common group of drugs that are known to cause DRESS?
What is one common group of drugs that are known to cause DRESS?
Which of the following metabolic deficiencies is often associated with DRESS caused by aromatic anticonvulsants?
Which of the following metabolic deficiencies is often associated with DRESS caused by aromatic anticonvulsants?
What is the primary treatment approach for managing DRESS?
What is the primary treatment approach for managing DRESS?
Which of the following statements about slow acetylators in the context of DRESS is accurate?
Which of the following statements about slow acetylators in the context of DRESS is accurate?
What are common initial findings on physical examination that may indicate a systemic drug reaction?
What are common initial findings on physical examination that may indicate a systemic drug reaction?
Which laboratory studies should be ordered for patients with suspected drug reactions?
Which laboratory studies should be ordered for patients with suspected drug reactions?
What is a characteristic feature of Acute Generalized Exanthematous Pustulosis (AGEP)?
What is a characteristic feature of Acute Generalized Exanthematous Pustulosis (AGEP)?
What is the primary cause of AGEP according to the provided information?
What is the primary cause of AGEP according to the provided information?
What type of medications are the most common causes of AGEP?
What type of medications are the most common causes of AGEP?
What significance does the timing of rash onset have in AGEP diagnosis?
What significance does the timing of rash onset have in AGEP diagnosis?
What are potential complications if AGEP treatment does not involve stopping the causative medication?
What are potential complications if AGEP treatment does not involve stopping the causative medication?
How should AGEP be managed in clinical practice?
How should AGEP be managed in clinical practice?
What is the primary difference in the percentage of skin sloughing that distinguishes SJS from TEN?
What is the primary difference in the percentage of skin sloughing that distinguishes SJS from TEN?
Which medication is least likely to be associated with TEN/SJS?
Which medication is least likely to be associated with TEN/SJS?
What percentage of skin sloughing defines SJS/TEN overlap?
What percentage of skin sloughing defines SJS/TEN overlap?
Which of the following best describes the mechanism of action of FasLigand in TEN/SJS?
Which of the following best describes the mechanism of action of FasLigand in TEN/SJS?
What is the recommended high-dose treatment for TEN/SJS delivered early in the disease?
What is the recommended high-dose treatment for TEN/SJS delivered early in the disease?
What role does the accumulation of toxic drug metabolites play in TEN/SJS?
What role does the accumulation of toxic drug metabolites play in TEN/SJS?
In cases of TEN, what other anatomical structures can experience sloughing besides the skin?
In cases of TEN, what other anatomical structures can experience sloughing besides the skin?
How does erythema multiforme primarily differ from SJS and TEN?
How does erythema multiforme primarily differ from SJS and TEN?
What common characteristics define a typical drug rash?
What common characteristics define a typical drug rash?
Which demographic factors increase the incidence of typical drug rashes?
Which demographic factors increase the incidence of typical drug rashes?
What is the mechanism by which the typical drug rash occurs?
What is the mechanism by which the typical drug rash occurs?
When does a typical drug rash usually begin after medication exposure?
When does a typical drug rash usually begin after medication exposure?
What should be done with medications identified as potential causes of a drug rash?
What should be done with medications identified as potential causes of a drug rash?
Which of the following is NOT a common causative drug class for typical drug rashes?
Which of the following is NOT a common causative drug class for typical drug rashes?
What symptom should be evaluated in a patient with a suspected drug rash to rule out systemic hypersensitivity?
What symptom should be evaluated in a patient with a suspected drug rash to rule out systemic hypersensitivity?
What kind of treatments are typically used for managing a typical drug rash?
What kind of treatments are typically used for managing a typical drug rash?
What is the typical duration for resolving the syndrome caused by toxic metabolites?
What is the typical duration for resolving the syndrome caused by toxic metabolites?
What is the recommended treatment if the disease is limited to skin involvement and peripheral eosinophilia?
What is the recommended treatment if the disease is limited to skin involvement and peripheral eosinophilia?
What is a significant consequence for patients who experience DRESS due to an aromatic anticonvulsant?
What is a significant consequence for patients who experience DRESS due to an aromatic anticonvulsant?
What should be monitored in patients who have experienced DRESS several months after the episode?
What should be monitored in patients who have experienced DRESS several months after the episode?
What is the rarity of Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS)?
What is the rarity of Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS)?
What common condition increases the risk of developing TEN and SJS?
What common condition increases the risk of developing TEN and SJS?
What characterizes the rash associated with TEN and SJS?
What characterizes the rash associated with TEN and SJS?
How long after starting the causative medication do TEN and SJS typically manifest?
How long after starting the causative medication do TEN and SJS typically manifest?
Flashcards
Typical Drug Rash
Typical Drug Rash
A common skin reaction in hospitalized patients often triggered by medications like antibiotics, sulfa drugs, and anticonvulsants. It presents as pink-to-red spots, bumps, and patches without scaling, causing itchiness.
Exanthematous Drug Rash
Exanthematous Drug Rash
A type of drug rash that typically occurs within 1-14 days after the first dose of a medication. It can last for up to 14 days after the medication is stopped.
Maculopapular Drug Rash
Maculopapular Drug Rash
A type of drug rash characterized by flat, red, and raised patches of skin, often seen during a drug reaction.
T-cell-mediated Drug Rash
T-cell-mediated Drug Rash
Signup and view all the flashcards
Symptomatic Management of Drug Rash
Symptomatic Management of Drug Rash
Signup and view all the flashcards
Treating Through
Treating Through
Signup and view all the flashcards
Medication List Review
Medication List Review
Signup and view all the flashcards
Evaluating for Systemic Hypersensitivity Reaction
Evaluating for Systemic Hypersensitivity Reaction
Signup and view all the flashcards
Acute Generalized Exanthematous Pustulosis (AGEP)
Acute Generalized Exanthematous Pustulosis (AGEP)
Signup and view all the flashcards
Lymphadenopathy, purpura, mucous membrane abnormalities
Lymphadenopathy, purpura, mucous membrane abnormalities
Signup and view all the flashcards
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS)
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS)
Signup and view all the flashcards
β-lactam antibiotics
β-lactam antibiotics
Signup and view all the flashcards
Macrolide antibiotics
Macrolide antibiotics
Signup and view all the flashcards
Calcium-channel blockers
Calcium-channel blockers
Signup and view all the flashcards
Stopping the causative medication
Stopping the causative medication
Signup and view all the flashcards
Treating through AGEP
Treating through AGEP
Signup and view all the flashcards
Toxic Epidermal Necrolysis (TEN)
Toxic Epidermal Necrolysis (TEN)
Signup and view all the flashcards
Stevens-Johnson Syndrome (SJS)
Stevens-Johnson Syndrome (SJS)
Signup and view all the flashcards
Epidermal Death in TEN and SJS
Epidermal Death in TEN and SJS
Signup and view all the flashcards
Initial Rash in TEN and SJS
Initial Rash in TEN and SJS
Signup and view all the flashcards
Rash Progression in TEN and SJS
Rash Progression in TEN and SJS
Signup and view all the flashcards
Epidermal Sloughing in TEN and SJS
Epidermal Sloughing in TEN and SJS
Signup and view all the flashcards
Mucous Membrane Involvement in TEN and SJS
Mucous Membrane Involvement in TEN and SJS
Signup and view all the flashcards
Frequency of TEN and SJS
Frequency of TEN and SJS
Signup and view all the flashcards
What is DRESS Syndrome?
What is DRESS Syndrome?
Signup and view all the flashcards
What is Coumadin Necrosis?
What is Coumadin Necrosis?
Signup and view all the flashcards
How does the rash in DRESS present?
How does the rash in DRESS present?
Signup and view all the flashcards
What are the common symptoms of DRESS?
What are the common symptoms of DRESS?
Signup and view all the flashcards
Why does Coumadin cause necrosis?
Why does Coumadin cause necrosis?
Signup and view all the flashcards
What are the common lab findings in DRESS?
What are the common lab findings in DRESS?
Signup and view all the flashcards
What makes Coumadin necrosis more likely?
What makes Coumadin necrosis more likely?
Signup and view all the flashcards
How is Coumadin necrosis prevented?
How is Coumadin necrosis prevented?
Signup and view all the flashcards
What are the most common drugs that cause DRESS?
What are the most common drugs that cause DRESS?
Signup and view all the flashcards
How long should heparin be used for Coumadin necrosis prevention?
How long should heparin be used for Coumadin necrosis prevention?
Signup and view all the flashcards
What is the proposed mechanism for DRESS with aromatic anticonvulsants?
What is the proposed mechanism for DRESS with aromatic anticonvulsants?
Signup and view all the flashcards
What is the proposed mechanism for DRESS with sulfonamides?
What is the proposed mechanism for DRESS with sulfonamides?
Signup and view all the flashcards
What is the most important treatment for DRESS?
What is the most important treatment for DRESS?
Signup and view all the flashcards
Erythema Multiforme
Erythema Multiforme
Signup and view all the flashcards
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Signup and view all the flashcards
FasLigand
FasLigand
Signup and view all the flashcards
Keratinocytes
Keratinocytes
Signup and view all the flashcards
Intravenous Immunoglobulin (IVIG)
Intravenous Immunoglobulin (IVIG)
Signup and view all the flashcards
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Signup and view all the flashcards
Study Notes
Cutaneous Drug Reactions
- Divided into limited cutaneous, systemic, and serious reactions
- Drug rash/limited cutaneous reactions are common in hospitalized patients, increasing with age and number of medications, and more common in females.
- Characterized by pink-to-red macules, papules, plaques without scaling, often itchy.
- Frequently described as exanthematous or maculopapular, but specific descriptions (e.g., 1-3 cm pink plaques, covering 60% body, accentuated in warm areas) are preferred.
- Commonly caused by beta-lactam antibiotics, sulfa drugs, and anticonvulsants.
- Rash onset can range from 1-14 days after the first dose and last up to 14 days after stopping the medication.
- T-cell-mediated processes; drug binds to protein, complex is internalized by antigen-presenting cell, then presented to drive immune reaction.
- Treatment is symptomatic with oral antihistamines and topical steroids. Any drug started within two weeks prior to rash onset should be considered as a possible cause, even if stopped. Substitute with safe alternative if possible.
- Evaluating for fever, sore throat, shortness of breath, dark urine are crucial for systemic drug hypersensitivity suspicion.
- Physical examination should include lymphadenopathy, purpura, mucous membrane abnormalities, blisters, and target lesions.
Acute Generalized Exanthematous Pustulosis (AGEP)
- Less common than typical cutaneous drug reactions.
- Characterized by erythema, often in the groin, axillae, or inner thighs, with tiny pustules (1 mm) visible on close inspection.
- Pustules and erythema can spread rapidly over the body. Spiking fevers and elevated neutrophil counts are common.
- Commonly caused by beta-lactam antibiotics, macrolides, and calcium-channel blockers.
- Onset of rash and fever usually within 1-2 days of starting offending drug.
- T-cell mediated reaction, likely mediated by neutrophils.
- Treatment involves stopping the causative drug, which was started within 3 days of rash onset.
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS)
- About as common as AGEP but far less than regular drug rashes.
- Onset later than other drug eruptions (2-6 weeks after starting drug).
- Initially appears similar to typical drug rash, but quickly develops widespread, confluent erythema with skin swelling. Face and neck often involved first.
- Facial edema with erythema and sore throat, and significant lymphadenopathy are strongly suggestive of DRESS.
- Treatment focuses on stopping the causative medication.
Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS)
- Rare, related diseases caused by medication adverse reactions.
- Characterized by epidermal death and sloughing, differing only in the extent of skin involvement.
- TEN affects at least 30% of skin, while SJS affects less than 10%
- TEN and SJS typically emerge 1-3 weeks after initiating the drug.
- Rash begins as painful, erythematous macules on the trunk and/or palms progressing to dusky erythema with sloughing of epidermis, blister or sheet-like.
- Mucous membranes are often involved.
- Treatment involves immediate cessation of causative agent and supportive care.
Coumadin Necrosis
- Uncommon adverse reaction to coumadin therapy.
- Often affects overweight women.
- Starts with pain, followed by erythema progressing to purpura and necrosis, frequently in skin overlying fat (breast, thighs, buttocks).
- Caused by thrombosis in small vessels of subcutaneous fat due to a transient hypercoagulable state. Temporary depletion of anticoagulants (protein C, etc) precedes the clotting.
- Prevention involves initiating heparin therapy before starting coumadin to prevent the temporary coagulopathies.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz covers cutaneous drug reactions, including limited cutaneous, systemic, and serious types. Explore the characteristics, common causes, and treatment options for drug-related rashes, with emphasis on T-cell-mediated processes. Assess your understanding of the specific descriptions and treatments associated with these reactions.